Literature DB >> 14994731

Ciprofloxacin-induced acute liver injury: case report and review of literature.

Annette Zimpfer1, Albert Propst, Gregor Mikuz, Wolfgang Vogel, Luigi Terracciano, Sylvia Stadlmann.   

Abstract

Ciprofloxacin is a fluorinated quinolone antibiotic with relatively low occurrence of adverse side effects. However, increasing evidence suggests that ciprofloxacin may cause severe liver damage. Until now, 14 cases of ciprofloxacin-associated liver injuries have been reported. We describe a case of a 22-year-old male who developed hepatic failure after intake of ciprofloxacin. The patient had been treated with 2 x 250 mg ciprofloxacin per day. He presented with symptoms of acute liver failure 14 days later. Liver biopsy revealed extensive hepatocellular necrosis involving zones 3 and 2 of hepatic acini and a mixed inflammatory infiltration containing abundant eosinophils. Symptoms resolved after corticoidsteroid therapy. In the present paper, we report the clinico-pathological characteristics of a case of ciprofloxacin-associated acute hepatic failure and discuss the current literature.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14994731     DOI: 10.1007/s00428-003-0917-9

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  15 in total

1.  Fulminant hepatic failure possibly related to ciprofloxacin.

Authors:  B K Grassmick; V T Lehr; A S Sundareson
Journal:  Ann Pharmacother       Date:  1992-05       Impact factor: 3.154

2.  Cholestatic hepatitis related to quinolones: a report of two cases.

Authors:  M L Hautekeete; M M Kockx; S Naegels; J K Holvoet; H Hubens; G Kloppel
Journal:  J Hepatol       Date:  1995-12       Impact factor: 25.083

3.  Liver disfunction due to ciprofloxacin.

Authors:  M Alcalde; M S Donoso; M Carcfa-Diaz; J M Pascasio; I Narvaez
Journal:  Acta Gastroenterol Belg       Date:  1995 Sep-Dec       Impact factor: 1.316

4.  Alteration of pharmacokinetics of cyclophosphamide and suppression of the cytochrome p450 genes by ciprofloxacin.

Authors:  H-J Xie; U Broberg; L Griskevicius; S Lundgren; S Carlens; L Meurling; C Paul; A Rane; M Hassan
Journal:  Bone Marrow Transplant       Date:  2003-02       Impact factor: 5.483

5.  Fatal hepatic failure associated with ciprofloxacin.

Authors:  S Fuchs; Z Simon; M Brezis
Journal:  Lancet       Date:  1994-03-19       Impact factor: 79.321

6.  Cytotoxicity and uptake of pefloxacin, ciprofloxacin, and ofloxacin in primary cultures of rat hepatocytes.

Authors:  P Nordmann; A Pechinot; A Kazmierczak
Journal:  J Antimicrob Chemother       Date:  1989-09       Impact factor: 5.790

7.  Cholestatic jaundice induced by ciprofloxacin.

Authors:  J K Labowitz; W B Silverman
Journal:  Dig Dis Sci       Date:  1997-01       Impact factor: 3.487

8.  Non-fatal acute liver injury possibly related to high-dose ciprofloxacin.

Authors:  M Goetz; P R Galle; A Schwarting
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-05-09       Impact factor: 3.267

9.  Hepatitis associated with amoxicillin/clavulanic acid and/or ciprofloxacin.

Authors:  Syed A Zaidi
Journal:  Am J Med Sci       Date:  2003-01       Impact factor: 2.378

10.  Possible ciprofloxacin-induced acute cholestatic jaundice.

Authors:  O Sherman; J L Beizer
Journal:  Ann Pharmacother       Date:  1994-10       Impact factor: 3.154

View more
  11 in total

1.  Clinical and histopathologic features of fluoroquinolone-induced liver injury.

Authors:  Eric S Orman; Hari S Conjeevaram; Raj Vuppalanchi; James W Freston; James Rochon; David E Kleiner; Paul H Hayashi
Journal:  Clin Gastroenterol Hepatol       Date:  2011-02-26       Impact factor: 11.382

2.  Fluoroquinolone therapy and idiosyncratic acute liver injury: a population-based study.

Authors:  J Michael Paterson; Muhammad M Mamdani; Michael Manno; David N Juurlink
Journal:  CMAJ       Date:  2012-08-13       Impact factor: 8.262

3.  Azithromycin effectiveness against intracellular infections of Francisella.

Authors:  Saira Ahmad; Lyman Hunter; Aiping Qin; Barbara J Mann; Monique L van Hoek
Journal:  BMC Microbiol       Date:  2010-04-23       Impact factor: 3.605

4.  Multiple-dose safety, tolerability, and pharmacokinetics of oral nemonoxacin (TG-873870) in healthy volunteers.

Authors:  David T Chung; Cheng-Yuan Tsai; Shu-Jen Chen; Li-Wen Chang; Chi-Hsin R King; Ching-Hung Hsu; Kit-Mui Chiu; Hao-Chen Tan; Yu-Ting Chang; Ming-Chu Hsu
Journal:  Antimicrob Agents Chemother       Date:  2009-11-02       Impact factor: 5.191

Review 5.  Hypersensitivity reactions to fluoroquinolones.

Authors:  Kathrin Scherer; Andreas J Bircher
Journal:  Curr Allergy Asthma Rep       Date:  2005-01       Impact factor: 4.919

Review 6.  Fluoroquinolone-induced liver injury: three new cases and a review of the literature.

Authors:  Anna Licata; Claudia Randazzo; Ilaria Morreale; Giuseppe Butera; Natale D'Alessandro; Antonio Craxì
Journal:  Eur J Clin Pharmacol       Date:  2012-01-14       Impact factor: 3.064

Review 7.  Hepatic safety of antibiotics used in primary care.

Authors:  Raúl J Andrade; Paul M Tulkens
Journal:  J Antimicrob Chemother       Date:  2011-05-17       Impact factor: 5.790

8.  Detection of Ciprofloxacin in Urine through Sensitized Lanthanide Luminescence.

Authors:  Subhankar Singha; Kyo Han Ahn
Journal:  Sensors (Basel)       Date:  2016-12-05       Impact factor: 3.576

9.  Antibiotics threaten wildlife: circulating quinolone residues and disease in Avian scavengers.

Authors:  Jesús A Lemus; Guillermo Blanco; Javier Grande; Bernardo Arroyo; Marino García-Montijano; Felíx Martínez
Journal:  PLoS One       Date:  2008-01-16       Impact factor: 3.240

10.  Ciprofloxacin Exposure Leading to Fatal Hepatotoxicity: An Unusual Correlation.

Authors:  Carly Unger; Layth S Al-Jashaami
Journal:  Am J Case Rep       Date:  2016-09-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.